NFE2L2 and ovarian cancer: This expression pattern of NQO1 and NRF2 was also reported by Bao and colleagues, who detected an increased expression of NQO1 and its regulator NRF2 in cisplatin-resistant ovarian cancer cells A2780/CDDP compared to cisplatin-sensitive parental cell line A2780.